Abstract
Magnetic Resonance Imaging (MRI) visible perivascular spaces (PVS) have been associated with age, decline in cognitive abilities, interrupted sleep, and markers of small vessel disease. Therefore, several computational methods have been developed for their assessment from brain MRI. But the limits of validity of these methods under various spatial resolutions, and the accuracy in detecting and measuring the dimensions of these structures have not been established. We use a digital reference object (DRO) previously developed for this purpose, to construct an in-silico phantom for answering these questions; and validate it using a physical phantom. Our in-silico and physical phantoms use cylinders of different sizes as models for PVS. Using both phantoms, we also evaluate the influence of the “PVS” orientation on the accuracy of the diameter measured, different sets of parameters for two vesselness filters that have been used for enhancing tubular structures, namely Frangi and RORPO filters, and the influence of the vesselness filter per-se in the accuracy of the measurements. Our experiments indicate that PVS measurements in MRI are only a proxy of their true dimensions, as the boundaries of their representation are consistently overestimated. The success in the use of the Frangi filter for this task relies on a careful tuning of several parameters. The combination of parameters α=0.5, β=0.5 and c=500 proved to yield the best results. RORPO, on the contrary, does not have these requirements, and allows detecting smaller cylinders in their entirety more consistently in the ideal scenarios tested. The segmentation of the cylinders using the Frangi filter seems to be best suited for voxel sizes equal or larger than 0.4 mm-isotropic and cylinders larger than 1 mm diameter and 2 mm length. “PVS” orientation did not influence their measures for image data with isotropic voxel size. Further evaluation of the emerging deep-learning methods is still required, and these results should be tested in “real” world data across several diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is mainly funded by the Hilary and Galen Weston Foundation under the Novel Biomarkers 2019 scheme (ref UB190097) administered by the Weston Brain Institute. This study received also funds from the Fondation Leducq Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease (16 CVD 05); the MRC Doctoral Training Programme in Precision Medicine (JB); the Row Fogo Charitable Trust (MCVH, FC) (BRO-D.FID3668413); and the UK Dementia Research Institute at the University of Edinburgh funded by the Medical Research Council, Alzheimers Society and Alzheimers Research UK (JMW).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
